Valuable monitoring of tumor development – with Magnetic Resonance
Monitoring the development of tumors and lesions is very important during breast cancer therapy. A solution is required that provides full coverage of the breast and needed information - both anatomical and metabolic tissue information.
Our software solution syngo® VIEWS can help provide ongoing anatomical and functional information about the lesion throughout the therapy process.
Siemens' unique Tim (Total imaging matrix) technology delivers accelerated acquisition speed – while still providing the high spatial resolution.
In addition, syngo GRACE, our solution for quantitative MR breast spectroscopy, can provide quantified metabolic tissue information by utilizing Choline as a biomarker. syngo GRACE provides essential information about the biochemical composition of breast lesions, and helps increase confidence in the assessment of therapy efficacy.